Pasar al contenido principal

GRK2 COMO NODO DE SEÑALIZACION INTEGRADOR EN SITUACIONES FISIOPATOLOGICAS

SAF2017-84125-R

•
Nombre agencia financiadora Agencia Estatal de Investigación
Acrónimo agencia financiadora AEI
Programa Programa Estatal de I+D+i Orientado a los Retos de la Sociedad
Convocatoria Proyectos I+D+i Retos de Investigación
Año convocatoria 2017
Plan Estatal 2017-2020 Plan Estatal de Investigación Científica y Técnica y de Innovación
Centro beneficiario UNIVERSIDAD AUTONOMA DE MADRID

Resultados relacionados

Resultados totales (Incluyendo duplicados): 7
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Involvement of G protein-coupled receptor kinase 2 (GRK2) in the development of non-alcoholic steatosis and steatohepatitis in mice and humans

  • Cruces-Sande, Marta
  • Vila-Bedmar, Rocío
  • Arcones, Alba C.
  • González-Rodríguez, Águeda
  • Rada, Patricia
  • Gutiérrez-de-Juan, Virginia
  • Vargas-Castrillón, Javier
  • Iruzubieta, Paula
  • Sánchez-González, Cristina
  • Formentini, Laura
  • Crespo, Javier
  • García-Monzón, Carmelo
  • Martínez-Chantar, María Luz
  • Valverde, Ángela M.
  • Mayor Jr., Federico
  • Murga, Cristina
Insulin resistance (IR) and obesity are important risk factors for non-alcoholic fatty liver disease (NAFLD). G protein-coupled receptor kinase 2 (GRK2) is involved in the development of IR and obesity in vivo. However, its possible contribution to NAFLD and/or non-alcoholic steatohepatitis (NASH) independently of its role on IR or fat mass accretion has not been explored. Here, we used wild-type (WT) or GRK2 hemizygous (GRK2±) mice fed a high-fat diet (HFD) or a methionine and choline-deficient diet (MCD) as a model of NASH independent of adiposity and IR. GRK2± mice were protected from HFD-induced NAFLD. Moreover, MCD feeding caused an increased in triglyceride content and liver-to-body weight ratio in WT mice, features that were attenuated in GRK2± mice. According to their NAFLD activity score, MCD-fed GRK2± mice were diagnosed with simple steatosis and not overt NASH. They also showed reduced expression of lipogenic and lipid-uptake markers and less signs of inflammation in the liver. GRK2± mice preserved hepatic protective mechanisms as enhanced autophagy and mitochondrial fusion and biogenesis, together with reduced endoplasmic reticulum stress. GRK2 protein was increased in MCD-fed WT but not in GRK2± mice, and enhanced GRK2 expression potentiated palmitic acid-triggered lipid accumulation in human hepatocytes directly relating GRK2 levels to steatosis. GRK2 protein and mRNA levels were increased in human liver biopsies from simple steatosis or NASH patients in two different human cohorts. Our results describe a functional relationship between GRK2 levels and hepatic lipid accumulation and implicate GRK2 in the establishment and/or development of NASH., Ministerio de Economia y Competitividad (MINECO/FEDER), Spain (grants SAF2014-55511-R and SAF2017-84125-R to F.M and C. M., grant SAF2015-65267-R to A.M.V., grant SAF2016-76028R to L.F. and SAF2017-87301-R to M.L.M.-C); Comunidad de Madrid-B2017/BMD-3671-INFLAMUNE to F.M.; Gobierno Vasco-Departamento de Salud 2013111114 and EITB Maratoia BIO15/CA/014 (to M.L.M.C); European Foundation for the Study of Diabetes (EFSD) Novo Nordisk Partnership for Diabetes Research in Europe Grant (to F.M.); Asociacion Espanola contra el Cancer (M.L.M-C) and Fundacion Ramon Areces (to C.M.). Instituto de Salud Carlos III (with European FEDER contribution) funds CIBERCV (grant CB16/11/00278 to F.M), CIBERDEM and CIBERehd, Peer Reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Sex differences in high fat diet-induced metabolic alterations correlate with changes in the modulation of GRK2 levels

  • Arcones, Alba C.
  • Cruces-Sande, Marta
  • Ramos Parrón, Paula
  • Mayor Menéndez, Federico
  • Murga, Cristina
A differential sex-related sensitivity has been reported in obesity and insulin resistance-related cardio-metabolic diseases, with a lower incidence of these pathologies being observed in young females when compared to age-matched males. However, such relative protection is lost with age. The mechanisms underlying such sex and age-related changes in the susceptibility to diabetes and obesity are not fully understood. Herein, we report that the relative protection that is displayed by young female mice, as compared to male littermates, against some of the metabolic alterations that are induced by feeding a high fat diet (HFD), correlates with a lower upregulation of the protein levels of G protein-coupled receptor kinase (GRK2), which is a key regulator of both insulin and G protein-coupled receptor signaling, in the liver and adipose tissue. Interestingly, when the HFD is initiated in middle-aged (32 weeks) female mice, these animals are no longer protected and display a more overt obese and insulin-resistant phenotype, along with a more evident increase in the GRK2 protein levels in metabolically relevant tissues in such conditions. Our data suggest that GRK2 dosage might be involved in the sex and age-biased sensitivity to insulin resistance-related pathologies., Agencia Estatal de Investigación of Spain (grant SAF2014-55511-R and SAF2017-84125-R to F.M.J. and C.M.), CIBERCV-Instituto de Salud Carlos III, Spain (grant CB16/11/00278 to F.M., co-funded with European Regional Development Fund-FEDER contribution), Programa de Actividades en Biomedicina de la Comunidad de Madrid (grant B2017/BMD-3671-INFLAMUNE to F.M.J.) and Fundación Ramón Areces., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

G‐protein‐coupled receptor kinase 2 safeguards epithelial phenotype in head and neck squamous cell carcinomas

  • Palacios-García, Julia
  • Sanz-Flores, María
  • Asensio, Alejandro
  • Alvarado, Raul
  • Rojo-Berciano, Susana
  • Stamatakis, Konstantinos
  • Paramio, Jesús M.
  • Cano, Amparo
  • Nieto, M. Ángela
  • García-Escudero, Ramón
  • Mayor Jr., Federico
  • Ribas, Catalina
Head and neck squamous cell carcinoma (HNSCC) arises from the mucosal lining of the upper aerodigestive tract and display few treatment options in advanced stages. Despite increased knowledge of HNSCC molecular biology, the identification of new players involved in triggering HNSCC recurrence and metastatic disease is needed. We uncover that G‐protein‐coupled receptor kinase‐2 (GRK2) expression is reduced in undifferentiated, high‐grade human HNSCC tumors, whereas its silencing in model human HNSCC cells is sufficient to trigger epithelial‐to‐mesenchymal transition (EMT) phenotypic features, an EMT‐like transcriptional program and enhanced lymph node colonization from orthotopic tongue tumors in mice. Conversely, enhancing GRK2 expression counteracts mesenchymal cells traits by mechanisms involving phosphorylation and decreased functionality of the key EMT inducer Snail1. Our results suggest that GRK2 safeguards the epithelial phenotype, whereas its downregulation contributes to the activation of EMT programs in HNSCC., Our laboratories are supported by Agencia Estatal de Investigación of Spain (grants SAF2014‐55511‐R and SAF2017‐84125‐R to F.M.; SAF2015‐66015‐R and ISCIII PIE15/00081 to J.P.M.; SAF2016‐76504‐R to A.C. and BFU2014‐53128‐R to M.A.N.); CIBERCV‐Instituto de Salud Carlos III, Spain (grant CB16/11/00278 to F.M., co‐funded with European FEDER contribution), CIBERONC‐Instituto de Salud Carlos III (grant CB16/12/00228 and CB16/12/00295 to J.M.P. and A.C., respectively, co‐funded with European FEDER contribution); Instituto de Salud Carlos III, Spain (grant PI14/00201 and PI18/01662 to C.R.; PI18/00263 to R.G.E., co‐funded with European FEDER contribution) and Fundación Ramón Areces (to C.R and F.M.), Swiss National Science Foundation (grant 144637, 153099), Swiss Cancer League (grant KLS 3243‐08‐2013) and Fundacion Anemia de Fanconi (grant 2018/127) to R.G.E.; and Programa de Actividades en Biomedicina de la Comunidad de Madrid‐B2017/BMD‐3671‐INFLAMUNE to F.M. M.S.F. was recipient of a Postdoctoral fellowship from Comunidad de Madrid (PEFD‐2017‐POST/BMD‐4442) and A.A. holds a PhD Fellowship from FPI programme Agencia Estatal de Investigación (PRE2018‐084418). We also acknowledge institutional support to the CBMSO from Fundación Ramón Areces., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Cardiac GRK2 Protein Levels Show Sexual Dimorphism during Aging and Are Regulated by Ovarian Hormones

  • Arcones, Alba C.
  • Martínez-Cignoni, Melanie Raquel
  • Vila-Bedmar, Rocío
  • Yáñez, Claudia
  • Lladó, Isabel
  • Proenza, Ana M.
  • Mayor Jr., Federico
  • Murga, Cristina
© 2021 by the authors., Cardiovascular disease (CVD) risk shows a clear sexual dimorphism with age, with a lower incidence in young women compared to age-matched men. However, this protection is lost after menopause. We demonstrate that sex-biased sensitivity to the development of CVD with age runs in parallel with changes in G protein-coupled receptor kinase 2 (GRK2) protein levels in the murine heart and that mitochondrial fusion markers, related to mitochondrial functionality and cardiac health, inversely correlate with GRK2. Young female mice display lower amounts of cardiac GRK2 protein compared to age-matched males, whereas GRK2 is upregulated with age specifically in female hearts. Such an increase in GRK2 seems to be specific to the cardiac muscle since a different pattern is found in the skeletal muscles of aging females. Changes in the cardiac GRK2 protein do not seem to rely on transcriptional modulation since adrbk1 mRNA does not change with age and no differences are found between sexes. Global changes in proteasomal or autophagic machinery (known regulators of GRK2 dosage) do not seem to correlate with the observed GRK2 dynamics. Interestingly, cardiac GRK2 upregulation in aging females is recapitulated by ovariectomy and can be partially reversed by estrogen supplementation, while this does not occur in the skeletal muscle. Our data indicate an unforeseen role for ovarian hormones in the regulation of GRK2 protein levels in the cardiac muscle which correlates with the sex-dependent dynamics of CVD risk, and might have interesting therapeutic applications, particularly for post-menopausal women., We acknowledge support by the Agencia Estatal de Investigación (MINECO/FEDER), Spain (grant SAF2017-84125-R to FM and CM and grant SAF2016-80384 R to ILL and AMP); the CIBER de Enfermedades Cardiovasculares (CIBERCV, Instituto de Salud Carlos III) Spain (grant CB16/11/00278 to F.M., co-funded with European FEDER contribution), and the Programa de Actividades en Biomedicina de la Comunidad de Madrid (B2017/BMD-3671-INFLAMUNE to FM). MR M-C was funded by a grant from Balearic Islands Government (FPI/1888/2016), after being selected in the framework of an operating program co-financed by the European Social Fund., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Gαq activation modulates autophagy by promoting mTORC1 signaling

  • Cabezudo, Sofía
  • Sanz-Flores, María
  • Caballero, Álvaro
  • Tasset, Inmaculada
  • Rebollo, Elena
  • Díaz, Antonio
  • Aragay, Anna M.
  • Cuervo, Ana
  • Mayor Jr., Federico
  • Ribas, Catalina
The mTORC1 node plays a major role in autophagy modulation. We report a role of the ubiquitous Gαq subunit, a known transducer of plasma membrane G protein-coupled receptors signaling, as a core modulator of mTORC1 and autophagy. Cells lacking Gαq/11 display higher basal autophagy, enhanced autophagy induction upon different types of nutrient stress along with a decreased mTORC1 activation status. They are also unable to reactivate mTORC1 and thus inactivate ongoing autophagy upon nutrient recovery. Conversely, stimulation of Gαq/11 promotes sustained mTORC1 pathway activation and reversion of autophagy promoted by serum or amino acids removal. Gαq is present in autophagic compartments and lysosomes and is part of the mTORC1 multi-molecular complex, contributing to its assembly and activation via its nutrient status-sensitive interaction with p62, which displays features of a Gαq effector. Gαq emerges as a central regulator of the autophagy machinery required to maintain cellular homeostasis upon nutrient fluctuations., This work was supported by Ministerio de Economía; Industria y Competitividad (MINECO) of Spain (grant SAF2017-84125-R to F.M.), (grant BFU2017-83379-R to A.M.A.), Instituto de Salud Carlos III (PI18/01662 to CR, co-funded with European FEDER contribution), CIBERCV-Instituto de Salud Carlos III, Spain (grant CB16/11/00278 to F.M., co-funded with European FEDER contribution), Fundación Ramón Areces (to C.R. and F.M.) and Programa de Actividades en Biomedicina de la Comunidad de Madrid-B2017/BMD-3671-INFLAMUNE to F.M. and NIH grants AG021904 and AG038072 to A.M.C. We also acknowledge the support of a Contrato para la Formación del Profesorado Universitario (FPU13/04341) and (FPU14/06670), an EMBO short-term fellowship (ASTF 600-2016). We also acknowledge institutional support to the CBMSO from Fundación Ramón Areces.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

GRK2 regulates GLP-1R-mediated early phase insulin secretion in vivo

  • Arcones, Alba C.
  • Vila-Bedmar, Rocío
  • Mirasierra, Mercedes
  • Cruces-Sande, Marta
  • Vallejo, Mario
  • Jones, Ben
  • Tomas, Alejandra
  • Mayor Jr., Federico
  • Murga, Cristina
© The Author(s)., [Background]: Insulin secretion from the pancreatic β-cell is finely modulated by different signals to allow an adequate control of glucose homeostasis. Incretin hormones such as glucagon-like peptide-1 (GLP-1) act as key physiological potentiators of insulin release through binding to the G protein-coupled receptor GLP-1R. Another key regulator of insulin signaling is the Ser/Thr kinase G protein-coupled receptor kinase 2 (GRK2). However, whether GRK2 affects insulin secretion or if GRK2 can control incretin actions in vivo remains to be analyzed. [Results]: Using GRK2 hemizygous mice, isolated pancreatic islets, and model β-cell lines, we have uncovered a relevant physiological role for GRK2 as a regulator of incretin-mediated insulin secretion in vivo. Feeding, oral glucose gavage, or administration of GLP-1R agonists in animals with reduced GRK2 levels (GRK2+/− mice) resulted in enhanced early phase insulin release without affecting late phase secretion. In contrast, intraperitoneal glucose-induced insulin release was not affected. This effect was recapitulated in isolated islets and correlated with the increased size or priming efficacy of the readily releasable pool (RRP) of insulin granules that was observed in GRK2+/− mice. Using nanoBRET in β-cell lines, we found that stimulation of GLP-1R promoted GRK2 association to this receptor and that GRK2 protein and kinase activity were required for subsequent β-arrestin recruitment. [Conclusions]: Overall, our data suggest that GRK2 is an important negative modulator of GLP-1R-mediated insulin secretion and that GRK2-interfering strategies may favor β-cell insulin secretion specifically during the early phase, an effect that may carry interesting therapeutic applications., We acknowledge support by Ministerio de Economía y Competitividad (MINECO/FEDER), Spain (grant SAF2017-84125-R to FM and CM and BFU2017-89336-R to MV); CIBER de Enfermedades Cardiovasculares (CIBERCV). Instituto de Salud Carlos III, Spain (grant CB16/11/00278 to F.M., co-funded with European FEDER contribution); CIBER de Diabetes y Enfermedades Metabólicas Asociadas (Ciberdem), Instituto de Salud Carlos III (CB07/08/0029 to MV); and Programa de Actividades en Biomedicina de la Comunidad de Madrid-B2017/BMD-3671-INFLAMUNE to FM; Medical Research Council to AT and BJ.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Degradation of GRK2 and AKT is an early and detrimental event in myocardial ischemia/reperfusion

  • Penela, Petronila
  • Inserte, Javier|||0000-0003-2283-3591
  • Ramos, Paula
  • Rodríguez Sinovas, Antonio|||0000-0003-2930-8773
  • García-Dorado, David|||0000-0002-1126-1279
  • Mayor, F.
Background: Identification of signaling pathways altered at early stages after cardiac ischemia/reperfusion (I/R) is crucial to develop timely therapies aimed at reducing I/R injury. The expression of G protein-coupled receptor kinase 2 (GRK2), a key signaling hub, is up-regulated in the long-term in patients and in experimental models of heart failure. However, whether GRK2 levels change at early time points following myocardial I/R and its functional impact during this period remain to be established. Methods: We have investigated the temporal changes of GRK2 expression and their potential relationships with the cardioprotective AKT pathway in isolated rat hearts and porcine preclinical models of I/R. Findings: Contrary to the maladaptive up-regulation of GRK2 reported at later times after myocardial infarction, successive GRK2 phosphorylation at specific sites during ischemia and early reperfusion elicits GRK2 degradation by the proteasome and calpains, respectively, thus keeping GRK2 levels low during early I/R in rat hearts. Concurrently, I/R promotes decay of the prolyl-isomerase Pin1, a positive regulator of AKT stability, and a marked loss of total AKT protein, resulting in an overall decreased activity of this pro-survival pathway. A similar pattern of concomitant down-modulation of GRK2/AKT/Pin1 protein levels in early I/R was observed in pig hearts. Calpain and proteasome inhibition prevents GRK2/Pin1/AKT degradation, restores bulk AKT pathway activity and attenuates myocardial I/R injury in isolated rat hearts. Interpretation: Preventing transient degradation of GRK2 and AKT during early I/R might improve the potential of endogenous cardioprotection mechanisms and of conditioning strategies.